IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis.
Ontology highlight
ABSTRACT: Multiple sclerosis (MS) is an inflammatory demyelinating disease in which cytokines produced by immune cells that infiltrate the brain and spinal cord play a central role. We show here that the IL-12p35, the alpha subunit of IL-12 or IL-35 cytokine, might be an effective biologic for suppressing neuroinflammatory responses and ameliorating the pathology of experimental autoimmune encephalomyelitis (EAE), the mouse model of human MS. We further show that IL-12p35 conferred protection from neuropathy by inhibiting the expansion of pathogenic Th17 and Th1 cells and inhibiting trafficking of inflammatory cells into the brain and spinal cord. In addition, in vitro exposure of encephalitogenic cells to IL-12p35 suppressed their capacity to induce EAE by adoptive transfer. Importantly, the IL-12p
SUBMITTER: Choi JK
PROVIDER: S-EPMC5633738 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA